Complement receptors (C3b, C4b/C3d) unbalance on CLL lymphocytes.

Area of Science:

• Immunology
• Hematology
• Complement System

Background:

• Lymphocytes play a crucial role in immune responses.
• Complement receptors (CRLs) on lymphocytes are involved in immune regulation.
• Chronic Lymphatic Leukemia (CLL) is a hematological malignancy characterized by abnormal lymphocyte proliferation.

Purpose of the Study:

• To investigate complement receptor (CRL) expression on lymphocytes in healthy donors and CLL patients.
• To analyze the effect of treatment on CRL expression in CLL.
• To hypothesize the immunophenotype of proliferating lymphocytes in CLL.

Main Methods:

• Analysis of lymphocytes from human peripheral blood using immunoadherence assays.
• Quantification of lymphocytes bearing C3b, C4b, and C3d complement receptors (CRLs).
• Comparison of CRL expression between healthy controls, CLL patients, and CLL patients undergoing treatment.

Main Results:

• A significant increase in C3dCRL-bearing lymphocytes was observed in CLL patients compared to controls.
• Lymphocytes with immunoadherence receptors were also slightly augmented in CLL patients.
• CRL populations in CLL patients under treatment mirrored the profile of untreated CLL, suggesting non-selective reduction.

Conclusions:

• CLL lymphocytes exhibit altered complement receptor expression, particularly an elevation of C3dCRL.
• Current treatments may not selectively target specific CRL types on lymphocytes in CLL.
• The proliferating lymphocyte population in CLL is hypothesized to be predominantly sIg+, C3d+/C3b-, C4b-, with a subset also being C3d+/C3b+, C4b+.